Abstract
We sought to describe the use and outcomes of small, medium and large premounted stents in patients with congenital heart disease, including incidence of and risk factors for re-intervention and development of in-stent stenosis. Premounted stents offer several advantages over traditional manually crimped bare-metal stents, especially in small patients. There are no data describing the medium-term effectiveness and outcomes of premounted stents in congenital heart disease. We performed a single-center retrospective review of all small, medium and large premounted stents implanted over an 8-year period. Premounted stents were implanted in 71 vessels within 59 patients with a 97 % success rate. Regardless of implantation site, premounted stent implantation resulted in significant improvements in vessel size and pressure gradient (p < 0.0001). Over a median follow-up duration of 3.1 years [interquartile range (IQR) 1.3–5.2], 25 patients (43 %) required re-intervention (18 catheter based, 3 surgical and 4 hybrid) at a median time of 1.4 years (IQR 0.9–3.0) from implant. Factors associated with re-intervention included age ≤1.9 years [hazard ratio (HR) 2.4, p = 0.03], weight ≤11.5 kg (HR 2.5, p = 0.03) and bare-metal premounted stents compared to covered premounted stents (HR 4.2, p = 0.001). In-stent stenosis was diagnosed in 42 % of premounted stents which underwent follow-up angiography. No identified characteristics were associated with in-stent stenosis, including “oversizing” the premounted stent. Small, medium and large premounted stents are effective in treating vascular stenosis in congenital heart disease. Frequent follow-up is required, especially in smaller patients with expected somatic growth, and to evaluate for in-stent stenosis which occurs in nearly half of premounted stents.
Similar content being viewed by others
References
O’Laughlin MP, Perry SB, Lock JE, Mullins CE (1991) Use of endovascular stents in congenital heart disease. Circulation 83(6):1923–1939
Rosenthal E, Qureshi SA (1992) Stent implantation in congenital heart disease. Br Heart J 67(3):211–212
O’Laughlin MP, Slack MC, Grifka RG, Perry SB, Lock JE, Mullins CE (1993) Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation 88(2):605–614
O’Laughlin MP (1995) Balloon-expandable stenting in pediatric cardiology. J Interv Cardiol 8(5):463–475
Shaffer KM, Mullins CE, Grifka RG, O’Laughlin MP, McMahon W, Ing FF, Nihill MR (1998) Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol 31(3):661–667
Okubo M, Benson LN (2001) Intravascular and intracardiac stents used in congenital heart disease. Curr Opin Cardiol 16(2):84–91
Ing F (2002) Stents: what’s available to the pediatric interventional cardiologist? Catheter Cardiovasc Interv 57(3):374–386. doi:10.1002/ccd.10342
Stanfill R, Nykanen DG, Osorio S, Whalen R, Burke RP, Zahn EM (2008) Stent implantation is effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and long-term follow-up results. Catheter Cardiovasc Interv 71(6):831–841. doi:10.1002/ccd.21526
Peters B, Ewert P, Berger F (2009) The role of stents in the treatment of congenital heart disease: current status and future perspectives. Ann Pediatr Cardiol 2(1):3–23. doi:10.4103/0974-2069.52802
Hascoet S, Baruteau A, Jalal Z, Mauri L, Acar P, Elbaz M, Boudjemline Y, Fraisse A (2014) Stents in paediatric and adult congenital interventional cardiac catheterization. Arch Cardiovasc Dis 107(8–9):462–475. doi:10.1016/j.acvd.2014.06.005S1875-2136(14)00151-X
Hascoet S, Jalal Z, Baruteau A, Mauri L, Chalard A, Bouzguenda I, Piechaud JF, Thambo JB, Lefort B, Guerin P, Le Gloan L, Acar P, Houeijeh A, Godart F, Fraisse A (2015) Stenting in paediatric and adult congenital heart diseases: a French multicentre study in the current era. Arch Cardiovasc Dis. doi:10.1016/j.acvd.2015.07.002
Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316(12):701–706. doi:10.1056/NEJM198703193161201
Quandt D, Ramchandani B, Bhole V, Penford G, Mehta C, Dhillon R, Stumper O (2015) Initial experience with the cook formula balloon expandable stent in congenital heart disease. Catheter Cardiovasc Interv 85(2):259–266. doi:10.1002/ccd.25543
Stern HJ, Baird CW (2009) A premounted stent that can be implanted in infants and re-dilated to 20 mm: introducing the Edwards Valeo Lifestent. Catheter Cardiovasc Interv 74(6):905–912. doi:10.1002/ccd.22096
Butera G, Giugno L, Basile D, Piazza L, Chessa M, Carminati M (2015) The Edwards Valeo lifestents in the treatment and palliation of congenital heart disease in infants and small children. Catheter Cardiovasc Interv 86(3):432–437. doi:10.1002/ccd.25872
van Gameren M, Witsenburg M, Takkenberg JJ, Boshoff D, Mertens L, van Oort AM, de Wolf D, Freund M, Sreeram N, Bokenkamp R, Talsma MD, Gewillig M (2006) Early complications of stenting in patients with congenital heart disease: a multicentre study. Eur Heart J 27(22):2709–2715. doi:10.1093/eurheartj/ehl328
Meadows J, Teitel D, Moore P (2010) Anatomic and technical predictors of stent malposition during implantation for vascular obstruction in patients with congenital and acquired heart disease. JACC Cardiovasc Interv 3(10):1080–1086. doi:10.1016/j.jcin.2010.07.010
Meadows J, Teitel D, Moore P (2013) Use and performance of premounted stents compared to nonpremounted stents in pediatric and adult congenital cardiac catheterization. J Interv Cardiol 26(1):58–61. doi:10.1111/j.1540-8183.2012.00764.x
Ing FF, Grifka RG, Nihill MR, Mullins CE (1995) Repeat dilation of intravascular stents in congenital heart defects. Circulation 92(4):893–897
Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN (1995) Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation 92(4):881–885
McMahon CJ, El-Said HG, Grifka RG, Fraley JK, Nihill MR, Mullins CE (2001) Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol 38(2):521–526
Hallbergson A, Lock JE, Marshall AC (2014) Frequency and risk of in-stent stenosis following pulmonary artery stenting. Am J Cardiol 113(3):541–545. doi:10.1016/j.amjcard.2013.10.016
Aiyagari R (2011) Extensive distortion and dysfunction of an Edwards Valeo Lifestent placed for stenosis of the superior vena cava. Catheter Cardiovasc Interv 78(2):282–285. doi:10.1002/ccd.23088
Holzer RJ, Gauvreau K, Kreutzer J, Leahy R, Murphy J, Lock JE, Cheatham JP, Bergersen L (2011) Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv 4(3):287–296. doi:10.1161/CIRCINTERVENTIONS.110.961029
Kudumula V, Noonan P, Taliotis D, Duke C (2014) Implantation and preliminary follow-up of the Bard Valeo stent in pulmonary artery stenosis. Catheter Cardiovasc Interv 84(2):197–203. doi:10.1002/ccd.25443
Jacobs JP, Mavroudis C, Quintessenza JA, Chai PJ, Pasquali SK, Hill KD, Vricella LA, Jacobs ML, Dearani JA, Cameron D (2014) Reoperations for pediatric and congenital heart disease: an analysis of the Society of Thoracic Surgeons (STS) congenital heart surgery database. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 17(1):2–8. doi:10.1053/j.pcsu.2014.01.006
Dearani JA, Connolly HM, Martinez R, Fontanet H, Webb GD (2007) Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond. Cardiol Young 17(Suppl 2):87–96. doi:10.1017/S1047951107001199
Kretschmar O, Sglimbea A, Pretre R, Knirsch W (2009) Pulmonary artery stent implantation in children with single ventricle malformation before and after completion of partial and total cavopulmonary connections. J Interv Cardiol 22(3):285–290. doi:10.1111/j.1540-8183.2009.00460.x
Cunningham JW, McElhinney DB, Gauvreau K, Bergersen L, Lacro RV, Marshall AC, Smoot L, Lock JE (2013) Outcomes after primary transcatheter therapy in infants and young children with severe bilateral peripheral pulmonary artery stenosis. Circ Cardiovasc Interv 6(4):460–467. doi:10.1161/CIRCINTERVENTIONS.112.000061
Maglione J, Bergersen L, Lock JE, McElhinney DB (2009) Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv 2(1):52–58. doi:10.1161/CIRCINTERVENTIONS.108.826263
Sathanandam SK, Haddad LM, Subramanian S, Wright D, Philip R, Waller BR (2015) Unzipping of small diameter stents: an in vitro study. Catheter Cardiovasc Interv 85(2):249–258. doi:10.1002/ccd.25596
Butera G, Manica JL, Marini D, Piazza L, Chessa M, Filho RI, Sarmento Leite RE, Carminati M (2014) From bare to covered: 15-year single center experience and follow-up in trans-catheter stent implantation for aortic coarctation. Catheter Cardiovasc Interv 83(6):953–963. doi:10.1002/ccd.25404
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Boe, B.A., Zampi, J.D., Schumacher, K.R. et al. The Use and Outcomes of Small, Medium and Large Premounted Stents in Pediatric and Congenital Heart Disease. Pediatr Cardiol 37, 1525–1533 (2016). https://doi.org/10.1007/s00246-016-1466-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-016-1466-8